|
|
250 Campus Drive Marlborough, MA 1752 USA phone:508.263.2900 fax:508.229.2795
|
|
| Symbol |
CYTC |
| Exchange |
Nasdaq |
| Founded |
1987 |
| Employees |
1331 |
|
|
| www.cytyc.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Diagnostic products and surgical primarily for women's health. |
 |
| Management |
| Patrick J. Sullivan, President and CEO; John P. McDonough, VP of Operations, Business Development; A. Suzanne Meszner-Eltrich, Secretary and General Counsel; Daniel J. Levangie, VP of Commercial Operations: Timothy M. Adams: |
| |
|
|
|
|
|
|
|
| Keywords |
| women's health, women's, womenshealth, cervical cancer screening, breast cancer risk assessment, excessive menstrual bleeding, advamed |
|
|
|
| Description |
|
CYTYC Corporation designs, develops, manufactures, and markets clinical products that focuses on women's health, including cervical cancer screening, breast cancer risk assessment, treatment of excessive menstrual bleeding, and treatment of breast cancer. |
 |
| Products / Services |
The company operates in two segments, Diagnostic Products and Surgical Products.
|
 |
 |
|
|
|
|
|
|